“It has been a pleasure working with you as well.”
General Field: Immunology
Position at the Time of Case Filing: Research Assistant IV
Country of Origin: India
State of Residence at the Time of Filing: Delaware
Approval Notice Date: March 24th, 2022
Processing Time: 7 days (Premium Processing Requested)
“[The client] is a leading influence in vaccine development whose work has contributed to the emerging field of nano vaccines. [Client’s] research has improved the accessibility of nano vaccines by streamlining their manufacturing and providing an approach to producing these effective molecules through self-assembly in vivo. [Client’s] research is, therefore, invaluable to global efforts to improve the treatment of human diseases.”
“[The client] has undoubtedly made important additions to her field, which also promote the national interests of the United States. [The client] is an innovative researcher working precisely in this domain. Employing her unsurpassed expertise in immunology, she has developed standard protocols to evaluate the safety and effectiveness of inoculations. As her insightful research assessing the viability of vaccine candidates for SARS-CoV2 illustrates, [the client’s] assays fill a substantial need for advancing interventions for infectious disease, enabling researchers to explore an array of therapeutic agents and isolate the most effective options.”
These are two excerpts taken from the letters of recommendation that our EB1-A (Alien of Extraordinary Ability) client from India obtained at our behest. She is a research assistant IV in immunology with an M.S. degree in biological sciences. She is one of the few leading vaccine development experts in the area, and she has achieved a consistent and notable record of success as well. She is especially well-known for her work on functional immunoglobulin G detection. Additionally, her work has influenced the research of hundreds of her peers in the field, both in the United States and around the world.
The field has recognized her authority by inviting her to review and evaluate the work of her peers no fewer than 16 times. She has also actively engaged her peers in the field of immunology by authoring and co-authoring 9 peer-reviewed articles that have been published in international journals. Furthermore, her overall work related to functional immunoglobulin G detection, development of DNA vaccine candidates for various infectious diseases including COVID-19, etc. has been cited 620 times. This makes her one of the top 1% most highly cited authors publishing on topics in DNA vaccination over the past 3 years according to Microsoft Academic. Additionally, data procured from Google Scholar shows that these publications have been cited by researchers in at least 41 countries. Our team was also able to find evidence of her major funding source namely the Coalition for Epidemic Preparedness Innovations.
Thus it was evident to us as we made clear to the adjudication bench at USCIS too, that not only has our client shown that she meets at least three of the regulatory criteria, but the evidence in the aggregate also demonstrates her national and international acclaim and position at the very top of her field.
So thanks to Premium Processing and our team effort, when we received her EB1-A approval just 7 days after her filing, we were very happy to hear of it. We are glad to have had the opportunity to help her in this process and we wish her the best in life.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Free evaluation email: email@example.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to: